Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 3,352 | 3,224 | 3,450 | 2,479 | 2,052 |
| Operating Income | -3,352 | -3,224 | -3,450 | -2,479 | -2,052 |
| Interest Expense | 5 | 5 | 4 | 2 | 0 |
| Other Income | 2,857 | 4,127 | -5,006 | -7,236 | -141 |
| Pre-tax Income | -500 | 898 | -8,460 | -9,717 | -2,193 |
| Net Income Continuous | -500 | 898 | -8,460 | -9,717 | -2,193 |
| Net Income | $-500 | $898 | $-8,460 | $-9,717 | $-2,193 |
| EPS Basic Total Ops | -0.20 | 0.60 | -5.40 | -6.80 | -1.60 |
| EPS Basic Continuous Ops | -0.30 | 0.55 | -5.43 | -6.88 | -1.55 |
| EPS Diluted Total Ops | -0.20 | 0.60 | -5.40 | -6.80 | -1.60 |
| EPS Diluted Continuous Ops | -0.30 | 0.55 | -5.43 | -6.88 | -1.55 |
| EPS Diluted Before Non-Recurring Items | -1.60 | -1.80 | -5.40 | N/A | N/A |
| EBITDA(a) | $-3,209 | $-3,084 | $-3,313 | $-2,349 | $-1,940 |